OnKure Therapeutics, Inc.

NASDAQ:OKUR

Biotechnology

Healthcare
$2.82 +0.23%

+$0.01 today

Market cap
$114.22M
Beta
0.28
P/E (TTM)
-1.0
EPS (TTM)
-$4.30
52W Low $1.91High $5.38

Volume 0.17M

Average 0.37M

OKUR Other Current Assets

Current assets not reported separately, such as prepaid expenses.

OnKure Therapeutics, Inc.NASDAQ: OKUR

Other Current Assets · Q1 FY2026 · quarter ended Mar 2026

Other current assets rises 255.8% from a year ago

Other current assets stood at $5.38M at the end of Q1 FY2026, up 255.8% from a year earlier and up 200.5% from the prior quarter. Over 3 fiscal years it compounded at +28.7% a year.

Context

  • Other current assets amounted to 2.7% of total assets at the end of Q1 FY2026, up 1.2 pp from a year earlier.
  • Other current assets increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether other current assets keeps rising in the next quarterly balance sheet after a +255.8% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$5.38M+200.5% QoQ
Last fiscal yearDec 2025
$1.79M— YoY
Year agoMar 2025
$1.51M+255.8% since
Other Current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+255.8%——
1 year———
3-year CAGR+28.7%——
5-year CAGR——
10-year CAGR——

Other Current Assets history

USD · from the balance sheet

Latest · FY2025
1.79M USD
Year-over-year change
—
4-year CAGR
-26.3%

Other Current Assets vs competitors

How OKUR compares with its peers on the latest reported figures

  • OKUR's Mar 2026 other current assets of $5.38M is the highest of the 4 companies compared; the peer median is $1.23M.
  • Its year-over-year change of +255.8% is the highest of 4, against a peer median of -50.8%.
  • Other current assets amounts to 2.7% of total assets for OKUR, versus a peer median of 2.4%.
OKUR Competitors Peer median
Other Current Assets for OKUR and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
OKUROnKure Therapeutics, Inc.Mar 2026$5.38M +255.8%+28.7%2.7%
XLOXilio Therapeutics, Inc.Mar 2026$3.87M -6.1%-15.3%2.4%
PDSBPDS Biotechnology CorporationMar 2026$1.23M -50.8%-16.6%5.0%
ATNMActinium Pharmaceuticals, Inc.Jun 2026$0 -100.0%+51.7%0.0%
Peer median (excluding OKUR) $1.23M-50.8%-15.3%2.4%

Competitors are the stored peer set for OKUR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents124.66M11.54M29.88M110.76M59.05M
Short-term Investments23.01M0000
Net Receivables00000
Inventory00000
Other Current Assets6.06M840K001.79M
Total Current Assets153.73M13.62M33.77M113M60.84M
Property, Plant & Equipment (Net)212K2.05M1.91M1.8M1.01M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets78K329K58K109K273K
Total Non-current Assets290K2.38M1.97M1.9M1.28M
Total Assets154.02M16M35.73M114.91M62.12M
Account Payables02.52M3.42M2.97M1.43M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities6.2M1.46M1.66M3.17M1.25M
Total Current Liabilities6.2M5.54M7.29M10.53M5.92M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)167K0000
Other Non-current Liabilities444K64.39M129.83M012K
Total Non-current Liabilities611K64.88M130.29M549K12K
Total Liabilities6.81M70.42M137.58M11.08M5.93M
Common Stock3K1K01K1K
Retained Earnings(84.73M)(57.07M)(102.05M)(154.72M)(214.24M)
Accumulated OCI34K0000
Other Stockholders Equity00000
Minority Interest00000
Total Equity147.21M(54.42M)(101.84M)103.83M56.18M
Total Debt0637K674K1.09M549K
Net Debt(124.66M)(10.91M)(29.2M)(109.68M)(58.5M)

OnKure Therapeutics, Inc.

NASDAQ:OKUR

Intrinsic Alpha fair value

Locked

Current Price

$2.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.